fda semaglutide compounding news FDA moves to stop compounding GLP-1 drugs Compounded versions of weight loss – Semaglutide API sourcing for compounded

Importantly, these weight loss benefits were sustained with a reported weight loss of 5.7 kg over 52 weeks [66]

Gender Valsartan: Pharmacokinetics of valsartan does not differ significantly between males and females

But there are a lot of doctors and other practitioners out there prescribing compounded GLPs because they genuinely care about their patients who are suffering and often have no other option due to the cost of the drugs

Pricing in the research market may actually decrease initially as the compound becomes more widely manufactured, but could also become more restricted as regulatory attention increases